The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647.
Mastercard
MA · a US exchange · USD · Market cap $500.1B · 39,800 employees
Mastercard Incorporated, a technology company, provides transaction processing and other payment-related products and services in the United States and internationally.
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Mastercard holds its Markdown at $570.89. The statistical read favours the buyers, held for 64 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 64 days |
| Price at the screen | $570.89 |
| Valuation | 31.38 trailing · 24.79 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.74 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $507.69 fair value estimate, strong competitive moat, 14.10% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 11.1% above the base estimate.
Third-party analyst targets: 37 covering, consensus Strong Buy. The average target sits +17% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsMastercard's Profits Fall Foul of Ethical Standards
Imagine every time you swipe that red-and-gold card, a portion of the transaction fee goes to a company with questionable ethical practices. That's Mastercard for you—a tech company that facilitates transactions and payment services worldwide. Despite a robust 14% revenue growth and an impressive 46% profit margin, Mastercard fails our ethical screen, which is a critical filter for us at Titan Protect.
Why it stands out, or rather, why we pass, is due to Mastercard's strong financial performance; a 241% return on equity and a moat rating of 'strong' signal a company well-entrenched in its market. However, the consensus strong buy from 37 analysts and a median target price of $668 seems detached from our fair value of $506.69, indicating a potential overvaluation.
Yet, the real risk here is ethical. Mastercard fails our business activity screen, a criterion non-negotiable at Titan Protect. While the market may price it as a strong buy, our ethical-first approach compels us to sidestep such practices. Analysis, not advice.
| Forward P/E | 24.8xpriced for continued growth |
| Trailing P/E | 31.4xa premium valuation |
| EPS, trailing | 18.19 |
| EPS, forward | 23.03 |
| Revenue growth | +14.1%steady growth |
| Profit margin | 46.3%highly profitable on every dollar of sales |
| Return on equity | 241.2%an exceptional return on shareholder capital |
| FCF yield | 3.39% |
| Dividend yield | 70.00% |
| Debt to equity | 4.40heavy leverage: higher risk if revenue softens |
| Current ratio | 1.06adequate liquidity, worth monitoring |
| Beta | 0.74steadier than the market |
| Short interest, float | 0.01% |
| 52-week range | 464.52 - 601.62 |
| Moat | STRONG |
| Market cap | $500.1B |
| Employees | 39,800 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeMA trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 10.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 17%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (36 analysts) rates it strong buy, with a mean price target of $647.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Visa Slips as AI Agents Gain a Shared Passport GuruFocus.com · 18h ago
- Mastercard Gets In on Agentic Payment Systems of the Future Barrons.com · 18h ago
- Mastercard AI payment tool lets bots shop without approval Quartz · 20h ago
- Mastercard Joins Visa in Letting AI Bots Do Your Shopping The Wall Street Journal · 21h ago
- New Mastercard Ads Tap Small Business 'Dreamonomics' MediaPost · 21h ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-27 | SACHIN J. MEHRA | Chief Financial Officer | 22,648 | · | |
| 2026-02-27 | ARKELL SANDRA A | Officer | 923 | · | |
| 2026-02-27 | VOSBURG CRAIG | Officer | 17,730 | · | |
| 2026-02-27 | VERMA RICHARD R | Officer | 1,958 | · | |
| 2026-02-27 | HUNTSMAN JON M JR | Officer | 1,997 | · | |
| 2026-02-27 | LING HAI | Officer | 9,607 | · | |
| 2026-02-27 | LAMBERT JORN | Officer | 6,991 | · | |
| 2026-02-27 | KRAMER JILL | Officer | 1,860 | · | |
| 2026-02-27 | KIRKPATRICK LINDA PISTECCHIA | Officer | 11,101 | · | |
| 2026-02-27 | MUIGAI SUSAN W | Officer | 1,469 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 15K–50K |
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 1K–15K |
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 15K–50K |
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 15K–50K |
| 8 May2026 | Rick Allen | Republican | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $497.81 | -1.8% | · | $983 | -1.8% |
| 2 months | $498.66 | -1.9% | · | $981 | -1.9% |
| 3 months | $496.46 | -1.5% | $0.87 | $987 | -1.3% |
| 6 months | $561.56 | -12.9% | $1.74 | $874 | -12.6% |
| 1 year | $586.08 | -16.6% | $3.26 | $840 | -16.0% |
| 2 years | $444.00 | +10.2% | $6.10 | $1,115 | +11.5% |
| 3 years | $362.78 | +34.8% | $8.56 | $1,372 | +37.2% |
| 5 years | $355.02 | +37.8% | $12.54 | $1,413 | +41.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever MA does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.